Home CDMOs At The Core Of Next-Generation Pharma Models
 

Keywords :   


CDMOs At The Core Of Next-Generation Pharma Models

2016-05-02 10:34:21| drugdiscoveryonline Home Page

By William E. Weiser, Ph.D., Global Head, PDS Analytical Sciences In today’s pharmaceutical industry, the economic strains of keeping a company completely vertically integrated are no longer feasible. Smaller, virtual drug companies simply do not have the resources necessary to translate a molecule to a drug product, and larger companies can no longer endure the financial burden of keeping these resources in-house in the face of unpredictable pipelines. As these companies turn to outsourcing to bridge these gaps, they each bring a unique set of variables to the table that needs to be considered when forecasting manufacturing operations and supply chain management.

Tags: models core pharma nextgeneration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.1115kg 50mm
14.11ONE PIECE BOX
14.11DAIWA OCEAN STAR 500
14.11fender jhon mayer blackone
14.11 Angel Touch Plus vol.3
14.11Strymon BigSky
14.11
14.11 TOUR B X 2
More »